TherapeuticsMD, Inc. is a pharmaceutical royalty company that transitioned from a women's healthcare company in December 2022. It licenses products including IMVEXXY, BIJUVA, ANNOVERA, and prescription prenatal vitamins (BocaGreenMD, vitaMedMD brands) to Mayne Pharma for U.S. commercialization, and to Knight Therapeutics and Theramex for international markets. Revenue is primarily derived from royalties and milestone payments under these licensing agreements.
Q2 FY2026 — expected 2026-08-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001213900-26-036515 | EDGAR | 68K words |
| 2025-03-27 | 2024-12-31 | 0001013762-25-003442 | EDGAR | — |
| 2024-03-29 | 2023-12-31 | 0001213900-24-028003 | EDGAR | — |
| 2023-04-07 | 2022-12-31 | 0001564590-23-005514 | EDGAR | — |
| 2022-03-23 | 2021-12-31 | 0001564590-22-011525 | EDGAR | — |
| 2021-03-04 | 2020-12-31 | 0001387131-21-003140 | EDGAR | — |
| 2020-02-24 | 2019-12-31 | 0001387131-20-002086 | EDGAR | — |
| 2019-02-27 | 2018-12-31 | 0001387131-19-001471 | EDGAR | — |
| 2018-02-23 | 2017-12-31 | 0001387131-18-000776 | EDGAR | — |
| 2017-02-28 | 2016-12-31 | 0001387131-17-001111 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001213900-25-109381 | EDGAR | 20K words |
| 2025-08-12 | 2025-06-30 | 0001213900-25-075003 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001213900-25-042697 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001213900-24-096811 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0001213900-24-067771 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001213900-24-041738 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001193125-23-277143 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001193125-23-211458 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001193125-23-145064 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001564590-22-037666 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001564590-22-029490 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001564590-22-020440 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-30 | 0001213900-26-036519 | EDGAR | 1K words |
| 2026-01-21 | 0001213900-26-005779 | EDGAR | — |
| 2025-12-16 | 0001213900-25-122240 | EDGAR | — |
| 2025-11-13 | 0001213900-25-109479 | EDGAR | — |
| 2025-08-12 | 0001213900-25-074975 | EDGAR | — |
| 2025-05-13 | 0001213900-25-042663 | EDGAR | — |
| 2025-04-09 | 0001213900-25-030089 | EDGAR | — |
| 2025-03-27 | 0001013762-25-003407 | EDGAR | — |
| 2024-12-05 | 0001213900-24-106095 | EDGAR | — |
| 2024-11-12 | 0001213900-24-096804 | EDGAR | — |
370 total filings indexed. 338 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000025743 |
| Ticker | TXMD |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
| Website | https://www.therapeuticsmd.com |
| Listed | 2002-01-28 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report